Drug discovery: A jump-start for electroceuticals

By K. Famm, Brian Litt, Kevin J. Tracey, Ed Boyden, M. Slaoui. Nature, 2013

526 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Progress in Neuroengineering for brain repair: New challenges and open issues (2018, background): “The interest in novel technologies relies on the possibility to use targeted electrical stimulation delivered by smart microfabricated devices to replace pharmaceutical interventions, recently named in major journals as electroceutical (Famm et al., 2013; Reardon, 2014).”
Medical Internet of Things and Big Data in Healthcare (2016, background): “• Glaxo recently announced that it is investing in electro - ceuticals, bioelectrical drugs that work by micro-stimulation of nerves [13].”
Single-Cell Phenotyping within Transparent Intact Tissue Through Whole-Body Clearing (2014, unknown): “, 2000), could help inform improvements in existing therapies or spur the development of entirely novel therapeutic strategies, such as for bioelectronic medicines (Famm et al., 2013).”
Wireless Recording in the Peripheral Nervous System with Ultrasonic Neural Dust. (2016, unknown): “…peripheral neurostimulation devices, such as those used to treat sleep apnea (Strollo et al., 2014) or control bladder function in paraplegics (Creasey et al., 2001) have led clinicians and researchers to propose new disease targets ranging from diabetes to rheumatoid arthritis (Famm et al., 2013).”